Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ralph Weissleder, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ralph Weissleder and Katherine Yang.
Connection Strength

5.677
  1. Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN. Gastroenterology. 2021 03; 160(4):1345-1358.e11.
    View in: PubMed
    Score: 0.941
  2. Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy. Sci Transl Med. 2017 05 24; 9(391).
    View in: PubMed
    Score: 0.736
  3. Single cell resolution in vivo imaging of DNA damage following PARP inhibition. Sci Rep. 2015 May 18; 5:10129.
    View in: PubMed
    Score: 0.640
  4. Bioorthogonal approach to identify unsuspected drug targets in live cells. Angew Chem Int Ed Engl. 2013 Sep 27; 52(40):10593-7.
    View in: PubMed
    Score: 0.567
  5. Bioorthogonal imaging of aurora kinase A in live cells. Angew Chem Int Ed Engl. 2012 Jul 02; 51(27):6598-603.
    View in: PubMed
    Score: 0.521
  6. Bead-Based Extracellular Vesicle Analysis Using Flow Cytometry. Adv Biosyst. 2020 12; 4(12):e2000203.
    View in: PubMed
    Score: 0.233
  7. Characterization of single microvesicles in plasma from glioblastoma patients. Neuro Oncol. 2019 05 06; 21(5):606-615.
    View in: PubMed
    Score: 0.211
  8. Computational imaging reveals mitochondrial morphology as a biomarker of cancer phenotype and drug response. Sci Rep. 2016 09 09; 6:32985.
    View in: PubMed
    Score: 0.175
  9. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci Transl Med. 2015 Nov 18; 7(314):314ra183.
    View in: PubMed
    Score: 0.166
  10. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun. 2015 Oct 27; 6:8692.
    View in: PubMed
    Score: 0.165
  11. Optimized Near-IR Fluorescent Agents for in Vivo Imaging of Btk Expression. Bioconjug Chem. 2015 Aug 19; 26(8):1513-8.
    View in: PubMed
    Score: 0.161
  12. Imaging cellular distribution of Bcl inhibitors using small molecule drug conjugates. Bioconjug Chem. 2014 Nov 19; 25(11):2081-5.
    View in: PubMed
    Score: 0.154
  13. Red Si-rhodamine drug conjugates enable imaging in GFP cells. Chem Commun (Camb). 2014 May 04; 50(34):4504-7.
    View in: PubMed
    Score: 0.148
  14. Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors. Mol Cancer Ther. 2014 Apr; 13(4):986-95.
    View in: PubMed
    Score: 0.147
  15. Platinum compounds for high-resolution in vivo cancer imaging. ChemMedChem. 2014 Jun; 9(6):1131-5.
    View in: PubMed
    Score: 0.146
  16. Bioorthogonal small molecule imaging agents allow single-cell imaging of MET. PLoS One. 2013; 8(11):e81275.
    View in: PubMed
    Score: 0.144
  17. Imaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agents. Neoplasia. 2012 Mar; 14(3):169-77.
    View in: PubMed
    Score: 0.128
  18. Nanoparticle-mediated measurement of target-drug binding in cancer cells. ACS Nano. 2011 Nov 22; 5(11):9216-24.
    View in: PubMed
    Score: 0.125
  19. Bioorthogonal probes for polo-like kinase 1 imaging and quantification. Angew Chem Int Ed Engl. 2011 Sep 26; 50(40):9378-81.
    View in: PubMed
    Score: 0.124
  20. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med. 2017 05 10; 9(389).
    View in: PubMed
    Score: 0.046
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.